Shopping Cart 0
Cart Subtotal
USD 0

Royal DSM NV (DSM) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company serves customers in animal nutrition and health, packaging and graphic arts, building and construction, pharma solutions, electrical and electronics, automotive, medical, personal care, energy, food, furniture, life protection, beverages and dietary supplements, marine, paint and coatings, manufacturing and equipment, sports, leisure and consumer goods, and textiles and clothing sectors. The company has operations across Eastern Europe, Latin America, North America, Asia, and other regions. DSM is headquartered in Heerlen, the Netherlands.

Royal DSM NV (DSM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Royal DSM NV, Medical Equipment, Deal Details 10

Venture Financing 10

MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10

Bio2 Technologies Raises USD4.5 Million in Series C Financing 11

Essential Medical Raises USD15 Million in Series B Financing 12

Interface Biologics Raises Funds Through Extended Series B Venture Financing 13

Regentis Biomaterials Raises USD 10 Million In Series C Financing 14

Partnerships 15

DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15

Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16

Vention Medical Enters into Agreement with Royal DSM 17

Royal DSM Enters into Distribution Agreement with Sebbin 18

DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19

Debt Offering 20

Royal DSM Completes Public Offering Of Bonds Due 2024 For USD 684 Million 20

Royal DSM Completes Private Placement Of Bonds Due 2019 For USD 405 Million 21

Acquisition 22

DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For USD 360 Million 22

Royal DSM NV-Key Competitors 24

Royal DSM NV-Key Employees 25

Royal DSM NV-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 29

Recent Developments 31

Strategy And Business Planning 31

Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands 31

Financial Announcements 32

Aug 01, 2018: DSM announces H1 2018 results 32

May 08, 2018: DSM Reports Q1 2018 Results 33

Feb 15, 2018: DSM Reports 2017 Results 34

May 02, 2017: DSM Q1 2017 Results 41

Feb 15, 2017: DSM reports 2016 results 42

Feb 14, 2017: DSM new presentation of accounts as from Q4 2016 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Royal DSM NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Royal DSM NV, Medical Equipment, Key Facts, 2017 2

Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Royal DSM NV, Deals By Market, 2012 to YTD 2018 8

Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10

Bio2 Technologies Raises USD4.5 Million in Series C Financing 11

Essential Medical Raises USD15 Million in Series B Financing 12

Interface Biologics Raises Funds Through Extended Series B Venture Financing 13

Regentis Biomaterials Raises USD 10 Million In Series C Financing 14

DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15

Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16

Vention Medical Enters into Agreement with Royal DSM 17

Royal DSM Enters into Distribution Agreement with Sebbin 18

DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19

Royal DSM Completes Public Offering Of Bonds Due 2024 For USD 684 Million 20

Royal DSM Completes Private Placement Of Bonds Due 2019 For USD 405 Million 21

DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For USD 360 Million 22

Royal DSM NV, Key Competitors 24

Royal DSM NV, Key Employees 25

Royal DSM NV, Other Locations 26

Royal DSM NV, Subsidiaries 26

Royal DSM NV, Joint Venture 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Royal DSM NV, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.